Home arrow Publication Series arrow LSA Pharma arrow Competitor arrow Abgenix Inc - Competitor Report
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.

Publication Series arrow LSA Pharma arrow Competitor arrow Abgenix Inc - Competitor Report

Abgenix Inc - Competitor Report


Price: $350.00


Executive Summary

The Abgenix Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. The report also includes recent company news updates.

The Abgenix Inc Competitor report delivers the latest and the most comprehensive intelligence available on the key companies active within Abgenix Inc’s markets.

Table of Contents

  • Business Summary
  • Contact Information
  • Selected Financial Data
  • Company Details
  • Product Glance (Table/Graph)
  • Disease Hub Classification (Table/Graph)
  • Product Pipeline
  • Products
  • Competitor Details by Therapeutic Indication
  • Recent Updates
  • Sample Screenshot

Pages: 11


Life Science Analytics, Inc. (LSA), is a biomedical data company that provides comprehensive pipeline and financial information on more than 8,000 biomedical companies worldwide. Our data and research products serve executives in the pharmaceutical, biotech, and financial industries. LSA products provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes.

Life Science Analytics reports are based on the most comprehensive database of private and public biomedical companies available.

Updated daily, the database covers 8,000 companies, over 24,000 products across 17 therapeutic categories with 700 sub-categories. LSA distills and systematizes pipeline, financial, competitive product, mechanism of action, partnering, and patent information to provide it’s clients with the most comprehensive and up-to-date information available.

View other Competitor Reports from LSA

Other Similar Company Reports

Deals & AlliancesFinancialProduct Pipeline



:

 


Download Fax Order Form/ PO Form

Request free sample pages from this product















Featured Products


Future Focus: Gastrointestinal Stromal Tumor
$26 250.00
$19 687.50
You Save: 25.00%

Future Focus: Myelodysplastic Syndrome
$26 250.00
$19 687.50
You Save: 25.00%

Cancer Stem Cells: Emerging Therapeutic, Diagnostic and Market
$3 350.00
$2 680.00
You Save: 20.00%

Cancer Drug Resistance 2008
$2 995.00
$2 396.00
You Save: 20.00%

Search Products

Advanced Search

Your Cart

Show Cart
Your Cart is currently empty.
Advertisement
 
 
 
© 2008 BioMarket Group